|
One of America’s foremost pediatric endocrinologists, Francine R. Kaufman, M.D., is director of the Comprehensive Childhood Diabetes Center, and head of the Center for Endocrinology, Diabetes and Metabolism at Childrens Hospital Los Angeles.
Dr.Kaufman was elected as a member of the Institute of Medicine of the National Academies at its annual meeting on Oct. 23-24, 2005 at the National Academy of Sciences in Washington, D.C.
Dr. Kaufman is professor of pediatrics at the Keck School of Medicine of the University of Southern California and was honored at its Academic Honors Convocation on March 30, 2006, with a Distinguished Professor award, presented to those whose accomplishments have brought special renown to the University.
Dr. Kaufman is an attending physician at Childrens Hospital Los Angeles. She is a diplomat of the American Board of Pediatrics and is board certified in pediatric endocrinology and metabolism.
Dr. Kaufman received the 2006 Mathies Award for Vision & Excellence in Healthcare Leadership from the Partners in Care Foundation on May 3, 2006, at the Beverly Hills Hotel. The Mathies Award is presented each year by the Partners in Care Foundation to recognize a courageous and creative leader in healthcare administration and policy whose dedication and accomplishments are a model for others to emulate in changing the shape of healthcare.
Dr. Kaufman is the author of a new book, Diabesity (Bantam Dell/Random House) that takes us to the front lines of the fight against this preventable, but deadly disease and it offers an action plan for winning this critical battle.Diabesity was published on March 1, 2005, to critical acclaim. Cable News Network’s Wolf Blitzer has said of the book, Incredibly important Francine Kaufman will save lives. James R. Gavin, M.D., Ph.D., chair of the National Diabetes Education Program, has said, A compelling combination of medical insight and Fran Kaufman’s special passion for ways to prevent this devastating epidemic. Kelly D. Brownell, Ph.D., author of Food Fight and Director of the Yale Center for Eating and Weight Disorders, has said, A gem coupling insightful analysis with creative recommendations for what might be done.
Her research interests include type 1 diabetes mellitus, type 2 diabetes, galactosemia, bone mineralization, ambiguous genitalia, patterns of growth hormone secretion and growth failure, androgen metabolism in human skin, endocrine manifestations of childhood AIDS, optic nerve hypoplasia/septo optic dysplacia and hypopituitarism and homocysteine metabolism.
Dr. Kaufman, who has been funded by the National Institutes of Health since 1980, has received more than 40 grants and contracts from the federal government, as well as from corporations and foundations.
She is chair of the NIH-funded Studies to Treat or Prevent Type 2 Diabetes in Youth (STOPP-T2). The treatment arm, Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY), is the first clinical trial sponsored by the National Institutes of Health to focus on type 2 diabetes in youth, which will involve 12 other sites across the country. The trial is expected to last five years.
Dr. Kaufman is co-principal investigator of the Keck Diabetes Prevention Initiative, a joint initiative of the Keck School of Medicine of the University of Southern California and Childrens Hospital Los Angeles, designed to identify and address the interrelated factors that lead to obesity and diabetes in East Los Angeles and South Los Angeles. It will begin its work with a $2 million grant from the W.M. Keck Foundation to support an initial two-year planning process to advance an eight-year intervention in partnership with the Edward Roybal Comprehensive Health Center in East Los Angeles and the Hubert Humphrey Comprehensive Health Center in South Los Angeles.
She has been a consultant with numerous corporations, including as a member of the medical advisory board of Mini-Med Technologies (1993-2001; 2003-present), as well as with the Eli Lilly Corporation (1998-2002; 2003-present), NovoNordisk (1999-2002; 2003-present), Johnson & Johnson (2000-01; 2003), Life Scan, Inc. (2000-01; 2003-present), Pfizer, Inc. (2003) and Amylin (2003-present).
Dr. Kaufman holds patents on numerous intellectual properties. She is the inventor of Extend Bar (Clinical Products, Ltd.).
Dr. Kaufman has been active with the American Diabetes Association at the local, state and national levels:
ADA Los Angeles Chapter, including service on the professional and patient education committee (1985-present); board of directors (1986-present; president, 1988-90); caper committee (1986-present); and fundraising committee (1990-present).
|
